Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The Spearman test was used to evaluate the correlation between the expression of lncRNAs (H19 and TUG1) and the basic clinical characteristics of UC patients, including age, sex, disease duration, endoscopic Mayo scores, CRP, ESR, WBC, PLT, smoking, serum iron, ferritin, vitamin D3, and Hb.

Source: 3.2. Distinct Expression Pattern of lncRNAs in UCN Lesions Compared to UCR Ones. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Forty‐two UC patients who were naïve to anti‐TNF agents enrolled in this prospective cohort study as a discovery cohort.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

TUG1 and H19 lncRNAs Can Predict Anti‐TNF Unresponsiveness in Patients With Ulcerative Colitis: A Machine Learning-Based Approach

Cohort study · Mediators of Inflammation · 2026

Original publication title

TUG1 and H19 lncRNAs Can Predict Anti‐TNF Unresponsiveness in Patients With Ulcerative Colitis: A Machine Learning: Based Approach

Raheleh Heydari; Mohammad Javad Tavassolifar; Mohammad Hossein Derakhshan Nazari; Romina Roshannia; Shabnam Shahrokh; Maryam Parvizi; Mohammad Tayefeh Norooz; Anna Meyfour

Copyright © 2026 Raheleh Heydari et al. Mediators of Inflammation published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The present study aimed to explore the association of long noncoding RNAs (lncRNAs) with inflammation, disease activity, and predicting response to anti‐tumor necrosis factor (TNF)‐α therapy in patients with ulcerative colitis (UC). Whole blood samples and inflamed biopsies were collected from 42 UC patients at baseline (W0) and week 14 (W14) after receiving anti‐TNF treatment as a discovery cohort. Colonoscopy images, histopathological, and clinical symptoms were used to monitor disease activity and response to treatment. LncRNA expression analysis showed increased expression of H19 in the active lesions of UC nonresponders (UCNs) compared to UC responders (UCRs) at baseline, whereas taurine upregulated gene 1 (TUG1) expression was lower.

Higher expression of H19 in UCN compared to UCR was still observed at W14, whereas its expression was downregulated in UCR in the remission phase at W14 versus W0, suggesting it as a marker for monitoring disease activity. Moreover, colonic expression of H19 was positively correlated with erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP). In blood, both H19 and TUG1 showed increased expression in UCN versus UCR at baseline and W14. Three‐fold cross‐validation: based machine learning approach and receiver operating characteristic (ROC) curve analysis showed that H19 and TUG1 had strong predictive performance for anti‐TNF response, with accuracies of 90% and 93% in tissue and 85% and 60% in blood, respectively.

In the validation cohort (12 UCR and 10 UCN), expression patterns were reproduced, and predictive performance remained high. H19 showed better accuracy in blood (85%) than tissue (70%), while TUG1 performed best in tissue (92%) and also remained highly accurate in blood (94%). The distinct expression of lncRNAs showed that they could play an important role in the response of UC patients to treatment. They can be a potential biomarker to monitor disease activity and predict response to anti‐TNF treatment in UC patients.

Authors’ abstract

The present study aimed to explore the association of long noncoding RNAs (lncRNAs) with inflammation, disease activity, and predicting response to anti‐tumor necrosis factor (TNF)‐α therapy in patients with ulcerative colitis (UC). Whole blood samples and inflamed biopsies were collected from 42 UC patients at baseline (W0) and week 14 (W14) after receiving anti‐TNF treatment as a discovery cohort. Colonoscopy images, histopathological, and clinical symptoms were used to monitor disease activity and response to treatment. LncRNA expression analysis showed increased expression of H19 in the active lesions of UC nonresponders (UCNs) compared to UC responders (UCRs) at baseline, whereas taurine upregulated gene 1 (TUG1) expression was lower.

Higher expression of H19 in UCN compared to UCR was still observed at W14, whereas its expression was downregulated in UCR in the remission phase at W14 versus W0, suggesting it as a marker for monitoring disease activity. Moreover, colonic expression of H19 was positively correlated with erythrocyte sedimentation rate (ESR) and C‐reactive protein (CRP). In blood, both H19 and TUG1 showed increased expression in UCN versus UCR at baseline and W14. Three‐fold cross‐validation: based machine learning approach and receiver operating characteristic (ROC) curve analysis showed that H19 and TUG1 had strong predictive performance for anti‐TNF response, with accuracies of 90% and 93% in tissue and 85% and 60% in blood, respectively.

In the validation cohort (12 UCR and 10 UCN), expression patterns were reproduced, and predictive performance remained high. H19 showed better accuracy in blood (85%) than tissue (70%), while TUG1 performed best in tissue (92%) and also remained highly accurate in blood (94%). The distinct expression of lncRNAs showed that they could play an important role in the response of UC patients to treatment. They can be a potential biomarker to monitor disease activity and predict response to anti‐TNF treatment in UC patients.

Publication and source details

Original title: TUG1 and H19 lncRNAs Can Predict Anti‐TNF Unresponsiveness in Patients With Ulcerative Colitis: A Machine Learning: Based Approach

Raheleh Heydari; Mohammad Javad Tavassolifar; Mohammad Hossein Derakhshan Nazari; Romina Roshannia; Shabnam Shahrokh; Maryam Parvizi; Mohammad Tayefeh Norooz; Anna Meyfour

Mediators of Inflammation · 2026

Copyright © 2026 Raheleh Heydari et al. Mediators of Inflammation published by John Wiley & Sons Ltd.2026https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:53:31.272814+00:00

DOI: 10.1155/mi/9078048 · PMC12949365